{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Derivative use, Daily rebalancing compounding effect, High risk profile",
    "classification": "complex",
    "supporting_data": "The product is a 2x leveraged ETP Securities providing twice the daily performance of Berkshire Hathaway (BRK-B), which inherently involves leverage and daily rebalancing leading to compounding effects that can significantly deviate returns over holding periods longer than one day. The product uses collateralized structures and derivatives to achieve its investment objective, which introduces counterparty and collateral risks. It is explicitly stated that the product is not principal protected and may result in losses exceeding the initial investment. The recommended holding period is only one day, reflecting the complexity and risk of the product. The KID includes a comprehension alert stating the product is not simple and may be difficult to understand, confirming its complex classification. The product is not a UCITS fund but an Exchange Traded Product (ETP) with synthetic replication features and embedded leverage. According to MiFID II rules and ESMA guidelines, such leveraged synthetic products with derivative exposure and complex payoff profiles are classified as complex financial instruments requiring appropriateness assessments for retail investors. The presence of leverage, synthetic replication, derivative use, and the compounding effect of daily rebalancing are key factors driving the complex classification under MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57 criteria."
}